Cardio Diagnostics Holdings Inc. Warrant
CDIOW
About: Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
Employees: 9
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
470% more capital invested
Capital invested by funds: $39.6K [Q1] → $226K (+$186K) [Q2]
29% more funds holding
Funds holding: 7 [Q1] → 9 (+2) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.75% less ownership
Funds ownership: 1.85% [Q1] → 1.1% (-0.75%) [Q2]
Financial journalist opinion
We haven’t received any recent news articles for CDIOW